|
Post by David Grey on Apr 24, 2020 12:36:16 GMT -5
A phase 3, multicenter, randomizd, double-blind, placebocontrolled, clinical study to assess the efficacy and safety of linzagolix in subjects with moderate to severe endometriosis associated pain.
304 Ne 1St Street Old Town, FL 32626
(352) 490-4816
View Study Website Sponsored By: Southeast Clinical Research.net Stipend: $10 - $100 Length of Study: 60 weeks Research Facility: Out-Patient Gender: Both Age: 1 - 100 Washout Period: 90 days from Last Dosing Date to Admission Health Condition: Endometriosis More Information: Diagnosed with pelvic endometriosis in the last 10 years with supporting documentation in medical records.
BMI of >/= 18 and regular menstral cycle.
Moderate to severe endometriosis associated pain during screening period reported in electronic diary with 75% completion of diary.
Call (352) 490-4816
|
|
|
Post by David Grey on Apr 24, 2020 12:33:42 GMT -5
Collection of blood samples from subjects who have recovered from COVID-19 and healthy volunteers.
$50
Call (844) 246-8459
|
|
|
Post by David Grey on Apr 10, 2020 9:59:03 GMT -5
clinicalhero.com/questionnaire-covid-19/Would you or someone you know like to learn about participating in clinical studies to prevent or treat the COVID-19 coronavirus? These studies, which will be critical to help counter this virus or others like it in the future, will compensate you for your time (details to be provided). Study Scavenger and JALR a/k/a Clinical Hero, a leading clinical study recruitment company, would like to hear from you to keep you informed of studies. These studies will have a need for healthy people as well as those exposed to the coronavirus, or with other conditions. Please complete this brief questionnaire. All answers are accepted. Volunteers of all kinds will be needed. Please forward this page to your friends and family members. Not only are you helping to find potential treatments and cures, but if you or your friends and family become a volunteer, you may qualify to receive compensation! Thank you! clinicalhero.com/questionnaire-covid-19/
|
|
|
Post by David Grey on Apr 10, 2020 9:58:04 GMT -5
clinicalhero.com/questionnaire-covid-19/Would you or someone you know like to learn about participating in clinical studies to prevent or treat the COVID-19 coronavirus? These studies, which will be critical to help counter this virus or others like it in the future, will compensate you for your time (details to be provided). Study Scavenger and JALR a/k/a Clinical Hero, a leading clinical study recruitment company, would like to hear from you to keep you informed of studies. These studies will have a need for healthy people as well as those exposed to the coronavirus, or with other conditions. Please complete this brief questionnaire. All answers are accepted. Volunteers of all kinds will be needed. Please forward this page to your friends and family members. Not only are you helping to find potential treatments and cures, but if you or your friends and family become a volunteer, you may qualify to receive compensation! Thank you!clinicalhero.com/questionnaire-covid-19/
|
|
|
Post by David Grey on Mar 31, 2020 11:44:29 GMT -5
Official response from Parexel:
We were informed on Friday, March 27 that a Parexel employee working in our Baltimore Early Phase Clinical Unit (EPCU) received a positive test result for COVID-19. This individual last worked in the unit Friday, March 13 (more than 14 days ago). We value our relationship with you as a study volunteer and wanted to ensure we get this important information to you as quickly as possible.
The employee has been quarantined and is currently symptomatic of COVID-19. Typically, exposed individuals show symptoms in 14 days. We wanted to make you aware of this situation so you can monitor for any potential exposures or symptoms. You may wish to contact your local/state public health departments and check CDC guidance for further information regarding COVID-19.
We are closely monitoring the situation with our employee and encourage you to let us know if you experience any symptoms. Your well-being and safety along with the health of our employees, customers and sites remains our highest priority. Please reach out with any questions. Please feel free to call us at either:
During office hours reach out to your ES/CRC directly After business hours, call 667-210-5300
Thank you,
|
|
|
Post by David Grey on Nov 21, 2019 12:50:08 GMT -5
is testing an investigational drug, which is not approved by the Food and Drug Administration (FDA) or any health authority, and is not currently available on the market. The objective of this study is to determine safety, tolerability and pharmacokinetics (the amount of drug absorbed into your blood stream and how your body handles the drug) and pharmacodynamics (how the drug affects your body).
480 S. Us Hwy 45 Grayslake, IL 60046
(800) 827-2778
Sponsored By: Stipend: $0 - $9540 Length of Study: 6 weeks Research Facility: In-Patient Gender: Both Age: 30 - 65 Washout Period: 42 days from Last Dosing Date to First Dosing Health Condition: *Healthy Volunteers Studies
|
|
|
davita
Sept 18, 2019 13:43:30 GMT -5
Post by David Grey on Sept 18, 2019 13:43:30 GMT -5
Site is closed
|
|
|
Post by David Grey on Aug 22, 2019 14:17:37 GMT -5
Healthy and 18-55 years old? Available for 1 stay of 3 nights and 1 follow-up? Study #6022_A. Up to $1,500. Call PRA: 913-370-9908
|
|
|
Post by David Grey on Aug 13, 2019 9:49:47 GMT -5
Study #186902_A PRA: Healthy and age 18-65? Avail. for 6 nights and 1 follow-up? Study #6902_A. Up to $2,050, including $50 for screening. 913-370-9908. Study #172072_A Healthy, non-smoking and age 18-65? Available for 1 stay of 8 nights? Study #2072_A. Up to $2,500. Call PRA: 913-370-9908. Study #19217X_A PRA: Healthy and age 18-55? Avail. for 5 nights and 1 follow-up? Study #217X_A. Up to $2,500, including $50 for screening. 913-370-9908. Study #186802 PRA: Guys, healthy and age 18-40? Do a 9-night stay and 6 visits? Study #6802. Up to $6,450, including $300 for screening visits. 913-370-9908. Study #185312 Are you healthy and age 18-55? Avail. for 1 stay of 8 nights and 9 outpatient visits? Study #5312. Up to $5,200. Call PRA: 913-370-9908.
|
|
|
Post by David Grey on Jul 17, 2019 9:34:32 GMT -5
Study # 186902-A : men and women 18-65 years old PRA: Healthy and age 18-65? Avail. for 6 nights and 1 follow-up? Study #6902_A. Up to $2,050, including $50 for screening. 913-370-9908. Study # 19217X : men and women 18-55 years old PRA: Healthy and age 18-55? Avail. for 5 nights and 1 follow-up? Study #217X_A. Up to $2,050, including $50 for screening. 913-370-9908. Study # 19509X : men and women 18-45 years old PRA Health Sciences: Healthy and age 18-45? Avail. for 1 stay of 10 nights and 1 visit? Study #509X. Up to $3,150. Call: 913-370-9908. Study # 186802 : men 18-40 years old Guys, are you healthy and age 18-40? Avail. for 1 stay of 9 nights and 6 visits? Study #6802. Up to $6,450. Call PRA: 913-370-9908. Study #184662 : men and women ages 18-45 Healthy and 18-45 years old? Avail. for a 17-night stay and 1 follow-up phone call? Study #4662. Up to $4,775. Call PRA: 913-370-9908.
|
|
|
Post by David Grey on Apr 1, 2019 11:06:33 GMT -5
For more information or to find out if you may qualify, call 913-210-5588 today!
9755 Ridge Dr. Lenexa, KS 66219
(913) 210-5588
Sponsored By: PRA Health Sciences (Lenexa, KS) Stipend: Contact Research Site Directly for Stipend Length of Study: 8 weeks Research Facility: In-Patient Gender: Both Age: 18 - 55 Health Condition: *Healthy Volunteers Studies More Information: * Healthy men and women
* 18-55 years old
* Non-smokers
* BMI: 18-35
* Available for 1 stay of 14 nights and 1 follow-up visit
* Qualified study participants may receive compensation up to $4,000. Even if you don't qualify, you could receive up to $300 for referring a qualified study participant
|
|
|
Post by David Grey on Mar 14, 2019 10:47:06 GMT -5
This study involves up to 3 screening visits, 1 in-house stay of 5 days/4 nights,3 in-house stays of 2 days7/ 1 night, 1 in-house stay of 4 days / 3 nights and 7 outpatient visits
3001 South Hanover Street Baltimore, MD 21225
(877) 617-8839
Sponsored By: PAREXEL Stipend: $9000 - $9000 Length of Study: 7 weeks Research Facility: In-Patient Gender: Both Age: 18 - 55 Washout Period: 30 days from Completion Date to Screening Health Condition: *Healthy Volunteers Studies More Information: Non-Smokers
BMI 19-32
|
|
|
Post by David Grey on Mar 13, 2019 12:33:11 GMT -5
One - 7 Night Stay & 1 Phone Call
621 Rose St. Lincoln, NE 68502
(800) 609-7297
Sponsored By: Celerion Stipend: $2495 - $2495 Length of Study: 2 weeks Research Facility: In-Patient Gender: Both Age: 19 - 40 Washout Period: 30 days from Last Blood Draw Date to First Dosing Health Condition: *Healthy Volunteers Studies More Information: Age 19-40
BMI 18-32
One - 7 Night Stay & 1 Phone Call
|
|
|
Post by David Grey on Mar 12, 2019 16:55:42 GMT -5
Healthy Men Needed You may qualify for research study 8391-353 and receive up to $5600-$7800. • Healthy Non-Smoking Men Age 18-55 • Available for a stay of 22-30 nights and 2 conditional overnights all spanning over less than 2 months • Compensation up to $5600-$7800 for time and participation -------------------------------------------------------------------------------- Call or visit us online today! - 608-210-5454 www.CovanceClinicalTrials.com
|
|
|
Post by David Grey on Mar 8, 2019 13:00:32 GMT -5
ICON Early Phase Services is looking for men and women who are overweight or have obesity but otherwise healthy for a clinical research study.
8307 Gault Lane San Antonio, TX 78209
(210) 225-5437
View Study Website Sponsored By: ICON Early Phase Services Stipend: $8400 - $8400 Length of Study: 16 weeks Research Facility: Out-Patient Gender: Both Age: 22 - 55 Health Condition: *Healthy Volunteers Studies More Information: This study is being done to test an investigational product for weight management. The study drug will be administered by subcutaneous injections.
The very first appointment will be the information session where you will be given information about the study. Please note, you do not have to fast for the information visit. You will have the opportunity to ask questions and receive further information on the study and you will also be given an informed consent form. No study procedures will be performed at this first appointment and no fasting is required for the information session appointment. After you receive information on the study and have the opportunity to ask your questions, you may either decline participation in the study or agree to participate and sign the study informed consent form. If you agree to participate in the study, the study staff will schedule with you a screening visit appointment and will provide you with the requirements for the screening visit, inform you about what procedures will be done at the screening visit, may schedule you for a DEXA scan that will take place at another facility, and will discuss with you about what medical records and documents you should bring to the screening visit. Please review the information below and determine whether you are interested in the study and would like to schedule your information session appointment.
Vital signs, ECGs, physical examinations, DEXA scans, pregnancy test and pelvic ultrasound for females of childbearing potential, and drug and alcohol screens will be performed during the study. Blood and urine samples will also be obtained during this study.
After the information session appointment and if you agree to participate in the study and sign the study informed consent, you will be invited and scheduled to complete a screening visit.
To determine if you fully qualify, it will be necessary to obtain blood samples after a 12- hour fast. You have the option of fasting for the screening appointment, or, you may return at a later date. If ICON does not have your medical records on file, you may need to provide medical records at screening. For more information, see below. Qualified participants may be compensated up to $8,400 for time and travel. If you qualify to participate in the study, your participation will take appmately 3 months and you will need to attend:
6 overnights (over 4 periods) 13 outpatient visits NOTE: Some females may require extra visits
If you are able to answer “YES” to the following statements, you may qualify for this study.
I am a healthy adult who is overweight or has obesity and no significant medical conditions
I am Male and between 22 and 55 years old
I am Female and between 22 and 45 years old
My BMI is between 27.0 and 39.9 kg/m2 (inclusive)
I do not smoke or use any tobacco or nie products. I agree not to smoke for the duration of the study and to abide by the rules of the clinic, which is a non-smoking facility.
I have not participated in (nor am I currently participating in) any clinical research study of an approved or non-approved investigational medicinal product within 30 days before screening
I am a Female with regular menstrual cycles (defined as 24-35 day cycles between 1st day of menses for the two most recent menstrual periods)
If Female, I am not pregnant or breastfeeding and I do not intend to become pregnant
If Female, I am not post-menopausal
If Female, I am either surgically sterile by tubal ligation, or I agree to use a non-hormonal intrauterine device or diaphragm/cervical cap with spermicide in combination with condom for male partner(s). *See note at top of page regarding abstinence.
If Female, I have not used hormonal contraceptives (oral contraceptives, implant or hormonal intrauterine device) within 3 months before screening If Male, I have had a vasectomy, or, I agree to use a condom with spermicidal foam/gel/cream combined with an approved contraceptive od if my partner is capable of becoming pregnant (e.g., implants, injectables, oral contraceptives, intrauterine devices, diaphragm, or cervical cap with spermicide)
If Male, I agree not to donate sperm from screening to 90 days after last dose of study drug
I am able to communicate effectively in English with the study personnel
I do not anticipate a change in lifestyle (e.g., eating, exercise or sleeping pattern) during the study I do not have a risk of atherosclerotic cardiovascular disease (NOTE: for subjects age 40+)
I do not have a history or presence of any cardiovascular disease including stable and unstable angina, myocardial infarction, transient ischaemic attack, stroke, cardiac decompensation, arrhythmias and conduction diss
I do not have a history or presence of bone disease or an increased risk of bone fracture
I do not have a history or presence of cancer within the last 5 years prior to screening. (NOTE: Except for cured basal and squamous cell skin cancer and in-situ carcinomas.)
I do not have a history or presence of sleep apnea
I do not have any special diet requirements and I am willing to eat the food provided while on-site and overnight stays
I have not had any prior obesity surgery and I do not have a gastrointestinal implant
I have not had a clinically significant weight change (e.g., ≥5% change), I have not dieted within 90 days prior to screening, and I am not participating in an organized weight reduction program
I do not have any history of psychiatric diss (e.g., schizophrenia, bipolar dis, eating diss, depression or anxiety)
|
|